![Abivax Presents Impressive New Phase 2a ABX464 Ulcerative Colitis 6-Months Maintenance Study Data in Oral Plenary Session at Annual Congress of European Crohn's and Colitis Organisation (ECCO) | Abivax Abivax Presents Impressive New Phase 2a ABX464 Ulcerative Colitis 6-Months Maintenance Study Data in Oral Plenary Session at Annual Congress of European Crohn's and Colitis Organisation (ECCO) | Abivax](https://abivax.gcs-web.com/sites/g/files/knoqqb87736/themes/site/client_site/dist/images/abivax-ir-banner.jpg)
Abivax Presents Impressive New Phase 2a ABX464 Ulcerative Colitis 6-Months Maintenance Study Data in Oral Plenary Session at Annual Congress of European Crohn's and Colitis Organisation (ECCO) | Abivax
![IBD patients no longer tied to hospital thanks to new formulation meds - Pulse by Maeil Business News Korea IBD patients no longer tied to hospital thanks to new formulation meds - Pulse by Maeil Business News Korea](https://file.mk.co.kr/meet/neds/2023/03/image_readtop_2023_177421_16780708825377028.jpg)
IBD patients no longer tied to hospital thanks to new formulation meds - Pulse by Maeil Business News Korea
![ECCO: Improving outcomes for all cancer patients in Europe through multidisciplinarity - Research Outreach ECCO: Improving outcomes for all cancer patients in Europe through multidisciplinarity - Research Outreach](https://researchoutreach.org/wp-content/uploads/2018/06/4944_ECCO2018_125mm_x_70mm_v1_OL_HR.jpg)